Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients

J Mintzer, 2000, Anticholinergic side-effects of drugs in elderly people, J R Soc Med, 93, 457, 10.1177/014107680009300903

LE Tune, 2001, Anticholinergic effects of medication in elderly patients, J Clin Psychiatry, 62, 11

N Campbell, 2009, The cognitive impact of anticholinergics: a clinical review, Clin Interv Aging, 4, 225

CK Block, 2015, The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample, Arch Clin Neuropsychol, 30, 105, 10.1093/arclin/acu073

2012, American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, 60, 616, 10.1111/j.1532-5415.2012.03923.x

P Gallagher, 2008, STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int J Clin Pharmacol Ther, 46, 72, 10.5414/CPP46072

S Holt, 2010, Potentially inappropriate medications in the elderly: the PRISCUS list., Dtsch Arztebl Int, 107, 543

M Boustani, 2008, Impact of anticholinergics on the aging brain: a review and practical application, Aging Health, 4, 311, 10.2217/1745509X.4.3.311

X Cai, 2013, Long-term anticholinergic use and the aging brain, Alzheimers Dement, 9, 377, 10.1016/j.jalz.2012.02.005

N Lechevallier-Michel, 2005, Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study, Br J Clin Pharmacol, 59, 143, 10.1111/j.1365-2125.2004.02232.x

C Fox, 2011, Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study, J Am Geriatr Soc, 59, 1477, 10.1111/j.1532-5415.2011.03491.x

SL Gray, 2015, Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study, JAMA Intern Med, 175, 401, 10.1001/jamainternmed.2014.7663

F Jessen, 2010, Anticholinergic drug use and risk for dementia: target for dementia prevention, Eur Arch Psychiatry Clin Neurosci, 260, S111, 10.1007/s00406-010-0156-4

H Kersten, 2013, Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial, J Gerontol A Biol Sci Med Sci, 68, 271, 10.1093/gerona/gls176

YC Yeh, 2013, Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study, Geriatr Gerontol Int, 13, 694, 10.1111/ggi.12000

KE Mate, 2015, Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia, Drugs Aging, 32, 159, 10.1007/s40266-014-0230-0

DM Boudreau, 2011, Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes, J Am Geriatr Soc, 59, 2069, 10.1111/j.1532-5415.2011.03654.x

CE Durán, 2013, Systematic review of anticholinergic risk scales in older adults, Eur J Clin Pharmacol, 69, 1485, 10.1007/s00228-013-1499-3

T Mayer, 2015, Different methods, different results-how do available methods link a patient's anticholinergic load with adverse outcomes?, Eur J Clin Pharmacol, 71, 1299, 10.1007/s00228-015-1932-x

Aging Brain Care. Anticholinergic Cognitive Burden Scale—2012 Update. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.agingbraincare.org/uploads/products/ACB_scale_-_legal_size.pdf" xlink:type="simple">www.agingbraincare.org/uploads/products/ACB_scale_-_legal_size.pdf</ext-link>.

KG Gaßmann, 2012, Implementation and results of a geriatric medication database, Z Gerontol Geriatr, 45, 455

J Trögner, 2006, Geriatrics in Bavaria-Database (GiB-DAT): Basic data analysis of geriatric rehabilitation in Bavaria and analysis of inter-clinic variability (part II), Z Gerontol Geriatr, 39, 134

J Trögner, 2006, Geriatrics in Bavaria-Database (GiB-DAT): Conception, structure and results of implementation (part I), Z Gerontol Geriatr, 39, 126

MF Fromm, 2013, Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristics, Eur J Clin Pharmacol, 69, 975, 10.1007/s00228-012-1425-0

S Schächtele, 2014, Implementation of warnings from Dear Doctor Letters (Rote-Hand-Briefe): an analysis of medication data from a large cohort of elderly patients, Dtsch Arztebl Int, 111, 255

S Schächtele, 2016, Co-prescription of QT-interval prolonging drugs: an analysis in a large cohort of geriatric patients, PLoS One, 11, e0155649, 10.1371/journal.pone.0155649

Schächtele S, Maas R, Gaßmann K-G, Fromm MF. [Arzneimitteltherapiesicherheit in der Geriatrie—Analysen in der Geriatrie in Bayern-Datenbank (GiB-DAT)]. In: Duesberg F, editor. e-Health 2015. Solingen2014. p. 116–22.

MF Folstein, 1975, &quot;Mini-mental state&quot;. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189

MN Lopez, 2005, Psychometric properties of the Folstein Mini-Mental State Examination, Assessment, 12, 137, 10.1177/1073191105275412

TN Tombaugh, 1992, The mini-mental state examination: a comprehensive review, J Am Geriatr Soc, 40, 922, 10.1111/j.1532-5415.1992.tb01992.x

WHO Collaborating Centre for Drug Statistics Methodology. ATC—Structure and principles. Available: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.whocc.no/atc/structure_and_principles/" xlink:type="simple">http://www.whocc.no/atc/structure_and_principles/</ext-link>.

E Callegari, 2011, A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder, Br J Clin Pharmacol, 72, 235, 10.1111/j.1365-2125.2011.03961.x

M Chancellor, 2012, Anticholinergics for overactive bladder therapy: central nervous system effects, CNS Neurosci Ther, 18, 167, 10.1111/j.1755-5949.2011.00248.x

MB Chancellor, 2012, Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder, Drugs Aging, 29, 259, 10.2165/11597530-000000000-00000

NL Campbell, 2010, Use of anticholinergics and the risk of cognitive impairment in an African American population, Neurology, 75, 152, 10.1212/WNL.0b013e3181e7f2ab

ML Ancelin, 2006, Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study, BMJ, 332, 455, 10.1136/bmj.38740.439664.DE

C Fox, 2011, The impact of anticholinergic burden in Alzheimer&apos;s dementia-the LASER-AD study, Age Ageing, 40, 730, 10.1093/ageing/afr102

D Gnjidic, 2014, Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer&apos;s disease: a national population cohort study, PLoS One, 9, e83224, 10.1371/journal.pone.0083224